Latin America Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Latin America Insulin Delivery Devices Market is segmented by Device (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, Jet Injectors) and Geography (Mexico, Brazil, and the Rest of Latin America). The report offers the value (in USD) and Volume (in Unit) for the above segments.

Latin America Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Latin America Insulin Delivery Devices Market Size

View Global Report
Latin America Insulin Delivery Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 7.28 Million
Market Size (2030) USD 8.04 Million
CAGR (2025 - 2030) 2.00 %

Major Players

Latin America Insulin Delivery Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Latin America Insulin Delivery Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Latin America Insulin Delivery Devices Market Analysis

The Latin America Insulin Delivery Devices Market size is estimated at USD 7.28 million in 2025, and is expected to reach USD 8.04 million by 2030, at a CAGR of greater than 2% during the forecast period (2025-2030).

The pandemic that everyone was talking about before COVID-19, is a challenge to health systems and a threat to their financial viability. The improper use of corticosteroids and the presence of diabetes mellitus in patients during the Coronavirus Disease 2019 (COVID-19) pandemic marked the beginning of an increased incidence of fungal infections such as aspergillosis and mucormycosis in patients with this emerging viral infection. More than 200 cases have been reported in the literature in Latin America, ranging from Mexico to Argentina. The majority of cases have come from Brazil. Prior to COVID-19, the number of cases had been increasing while the mortality rate had been decreasing. Access to telemedicine is critical for managing chronic diseases in children, such as type 1 diabetes. 

Telemedicine was implemented in Latin American countries due to the COVID-19 pandemic, which positively impacted the health system. Telemedicine could result in financial savings by avoiding transportation expenses, class and parental working hours lost, time lost for transportation to distant referral health centres, and improving the quality of life, socioeconomic level, and environment."

Diabetes is one of the major health challenges of the twenty-first century, according to the Pan American Health Organization (PAHO). According to the organization's data, the number of people suffering from this condition will reach 642 million by 2040. One advantage of this solution is that it allows patients to communicate with a remote healthcare professional, avoiding the need to visit a healthcare facility and lowering the risk of contracting COVID-19 in this high-risk group. Diabetes affects approximately 41 million people in Latin America and 400 million worldwide. This figure is expected to rise over time, reaching 68 million diabetics in the region by 2040.

Technological advancements have increased over the period in Insulin delivery devices for safer and more accurate administration of insulin. In 2020, Medtronic launched its first integrated smart insulin pen. The Medtronic Integrated Insulin Pen provides real-time glucose readings of patients along with insulin dose information to manage their glucose levels.

The world is facing an unprecedented global health crisis, and it is critical that we support the implementation of technological solutions, such as Insulin devices, to collaborate on regional growth and continue to support the millions of people living with this condition.

Latin America Insulin Delivery Devices Industry Overview

The insulin delivery devices market is consolidated due to only a few major companies operating globally and regionally. The competitive landscape includes analyzing a few international and local companies that hold market shares and are well known, including Novo Nordisk, Sanofi, Eli Lily and Company, Medtronic, Insulet, Ypsomed, Becton Dickinson, and Company, among others.

Latin America Insulin Delivery Devices Market Leaders

  1. Ypsomed

  2. Medtronic

  3. Sanofi

  4. Eli Lilly

  5. Novo Nordisk

  6. *Disclaimer: Major Players sorted in no particular order
Latin America Insulin Delivery Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Latin America Insulin Delivery Devices Market News

  • March 2022: Novo Nordisk announced that two smart connected insulin pens, NovoPen 6 and NovoPen Echo Plus, were available on prescription for people with diabetes treated with Novo Nordisk insulin in the United Kingdom.
  • January 2022: Boston-based Insulet Corp. announced that the FDA (Food and Drug Administration) cleared the new Omnipod 5 system, marking the company's entry into the automated insulin delivery (AID) universe.

Latin America Insulin Delivery Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Drivers
  • 4.3 Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. Market Segmentation

  • 5.1 Device
    • 5.1.1 Insulin Pump
    • 5.1.1.1 Technology
    • 5.1.1.1.1 Tethered Insulin Pump
    • 5.1.1.1.2 Tubeless Insulin Pump
    • 5.1.1.2 Component
    • 5.1.1.2.1 Insulin Pump Devices
    • 5.1.1.2.2 Insulin Pump Reservoirs
    • 5.1.1.2.3 Infusion Sets
    • 5.1.2 Insulin pens
    • 5.1.2.1 Cartridges in reusable pens
    • 5.1.2.2 Disposable Pens
    • 5.1.3 Insulin Syringes
    • 5.1.4 Jet Injectors
  • 5.2 Geography
    • 5.2.1 Brazil
    • 5.2.2 Mexico
    • 5.2.3 Rest of North America

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes Population
  • 6.2 Type-2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Novo Nordisk AS
    • 7.1.2 Sanofi SA
    • 7.1.3 Eli Lilly and Company
    • 7.1.4 Medtronic PLC
    • 7.1.5 Insulet corporation
    • 7.1.6 Ypsomed
    • 7.1.7 Becton, Dickinson and Company
    • 7.1.8 Other Key Players
  • *List Not Exhaustive
  • 7.2 Company Share Analysis

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
* We will provide a segment-wise breakdown (Value and Volume) for all the countries covered under the Table of Contents. **Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments.
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Latin America Insulin Delivery Devices Industry Segmentation

There are several choices for delivering insulin to people with diabetes, including syringes, pens, pumps, and jet injectors. A syringe is a tool having a detachable needle guard, plunger, and hollow center. Latin America Insulin Delivery Devices Market is segmented by Device (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, Jet Injectors) and Geography (Mexico, Brazil, and the Rest of Latin America). The report offers the value (in USD) and Volume (in Unit) for the above segments. We will provide a segment-wise breakdown (Value and Volume) for all the countries covered under the Table of Contents.

Device Insulin Pump Technology Tethered Insulin Pump
Tubeless Insulin Pump
Component Insulin Pump Devices
Insulin Pump Reservoirs
Infusion Sets
Insulin pens Cartridges in reusable pens
Disposable Pens
Insulin Syringes
Jet Injectors
Geography Brazil
Mexico
Rest of North America
Need A Different Region or Segment?
Customize Now

Latin America Insulin Delivery Devices Market Research FAQs

How big is the Latin America Insulin Delivery Devices Market?

The Latin America Insulin Delivery Devices Market size is expected to reach USD 7.28 million in 2025 and grow at a CAGR of greater than 2% to reach USD 8.04 million by 2030.

What is the current Latin America Insulin Delivery Devices Market size?

In 2025, the Latin America Insulin Delivery Devices Market size is expected to reach USD 7.28 million.

Who are the key players in Latin America Insulin Delivery Devices Market?

Ypsomed, Medtronic, Sanofi, Eli Lilly and Novo Nordisk are the major companies operating in the Latin America Insulin Delivery Devices Market.

What years does this Latin America Insulin Delivery Devices Market cover, and what was the market size in 2024?

In 2024, the Latin America Insulin Delivery Devices Market size was estimated at USD 7.13 million. The report covers the Latin America Insulin Delivery Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Latin America Insulin Delivery Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Latin America Insulin Delivery Devices Industry Report

Statistics for the 2025 Latin America Insulin Delivery Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Latin America Insulin Delivery Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.